BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.900
+0.010 (0.35%)
Jun 15, 2026, 9:02 AM CET
BRAIN Biotech AG Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | -11.02 | -11.74 | -11.13 | -8.28 | -6.59 | -4.97 |
Depreciation & Amortization | 5.02 | 5.13 | 4.82 | 4.65 | 4.34 | 4.01 |
Loss (Gain) From Sale of Assets | -0.27 | 0.05 | -0 | -0 | -0.03 | 0.01 |
Loss (Gain) From Sale of Investments | - | - | - | -0.53 | -2.36 | -0.58 |
Loss (Gain) on Equity Investments | 0.48 | 0.53 | 0.5 | 1.49 | 2.43 | 1.72 |
Stock-Based Compensation | 0.78 | 0.78 | 0.89 | 0.8 | 0.75 | 0.51 |
Provision & Write-off of Bad Debts | - | - | 0 | -0.02 | 0 | -0 |
Other Operating Activities | 1.09 | 0.57 | -4.11 | -2.47 | -3.66 | -5.96 |
Change in Accounts Receivable | 0.53 | -0.89 | 1.8 | -1.33 | -0.23 | -0.14 |
Change in Inventory | 1.36 | 0.36 | 0.41 | -0.04 | -2.41 | -0.02 |
Change in Accounts Payable | -1.97 | -1.23 | -0.11 | -1.17 | 2.53 | 0.31 |
Change in Unearned Revenue | 0.07 | 0.47 | 2.36 | 3.49 | 2.51 | 1.72 |
Change in Other Net Operating Assets | -1.85 | -3.32 | 1.11 | -0.62 | 1.24 | -0.4 |
Operating Cash Flow | -5.61 | -9.23 | -3.58 | -4.22 | -1.49 | -3.91 |
Capital Expenditures | -2.05 | -1.53 | -1.55 | -2.62 | -5.8 | -1.25 |
Sale of Property, Plant & Equipment | 0.15 | 0.04 | 0.02 | 0.18 | 0.14 | 0 |
Cash Acquisitions | - | - | - | - | -3.1 | -0.44 |
Divestitures | - | - | - | 3.04 | -1.07 | - |
Sale (Purchase) of Intangibles | -0.1 | -0.07 | -0.18 | -0.02 | -0.28 | -0.01 |
Investment in Securities | - | - | - | -0.11 | -1.17 | -0.56 |
Other Investing Activities | 0.01 | 0.01 | 0.02 | 0.09 | -1.4 | 0.08 |
Investing Cash Flow | -1.98 | -1.56 | -1.69 | 0.56 | -12.69 | -2.18 |
Long-Term Debt Issued | - | 0.13 | 31.87 | 13 | 0.35 | 0.06 |
Long-Term Debt Repaid | - | -8.57 | -5.48 | -2.96 | -2.32 | -2.88 |
Net Debt Issued (Repaid) | -1.22 | -8.44 | 26.39 | 10.05 | -1.97 | -2.82 |
Issuance of Common Stock | - | - | 0.6 | - | - | 18.98 |
Other Financing Activities | -1.7 | -1.7 | - | -9.59 | - | -4.59 |
Financing Cash Flow | -2.92 | -10.14 | 26.99 | 0.46 | -1.97 | 11.57 |
Foreign Exchange Rate Adjustments | -0.11 | -0.05 | 0.1 | 0.11 | 0.04 | 0.12 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | -10.61 | -20.98 | 21.82 | -3.09 | -16.1 | 5.6 |
Free Cash Flow | -7.65 | -10.77 | -5.14 | -6.84 | -7.29 | -5.16 |
Free Cash Flow Margin | -15.83% | -21.44% | -9.25% | -12.16% | -14.49% | -13.15% |
Free Cash Flow Per Share | -0.35 | -0.49 | -0.23 | -0.31 | -0.33 | -0.26 |
Cash Interest Paid | 1.58 | 1.76 | 1.64 | 0.78 | 0.5 | 0.43 |
Cash Income Tax Paid | 0.04 | 0.06 | 0.04 | 0.2 | 0.26 | 0.33 |
Levered Free Cash Flow | -8.82 | -8.5 | 1.03 | -4.39 | -2.36 | -2.64 |
Unlevered Free Cash Flow | -7.25 | -7.12 | 2.24 | -3.86 | -2.03 | -2.31 |
Change in Working Capital | -1.69 | -4.54 | 5.44 | 0.14 | 3.64 | 1.35 |